25iP-NBOMe

25iP-NBOMe
Clinical data
Other names	2C-iP-NBOMe; NBOMe-2C-iP
ATC code	none;
Legal status
Legal status	DE: NpSG (Industrial and scientific use only); UK: Class A;
Identifiers
	IUPAC name 2-(2,5-Dimethoxy-4-propan-2-ylphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine;
CAS Number	1391487-83-4 ;
PubChem CID	118796426;
ChemSpider	52085379 ;
UNII	575702U55U;
Chemical and physical data
Formula	C21H29NO3
Molar mass	343.467 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)C1=C(C=C(C(=C1)OC)CCNCC2=CC=CC=C2OC)OC;
	InChI InChI=1S/C21H29NO3/c1-15(2)18-13-20(24-4)16(12-21(18)25-5)10-11-22-14-17-8-6-7-9-19(17)23-3/h6-9,12-13,15,22H,10-11,14H2,1-5H3; Key:KMZZEEDFQLXSQF-UHFFFAOYSA-N;

25iP-NBOMe, also known as 2C-iP-NBOMe or NBOMe-2C-iP, is a derivative of the phenethylamine hallucinogen 2C-iP, which acts as a highly potent agonist for the human 5-HT_2A receptor.